Abstract:Tumor-associated macrophages (TAMs) are predominantly present in the tumor microenvironment (TME) and play a crucial role in shaping the efficacy of tumor immunotherapy. These TAMs primarily exhibit a tumor-promoting M2-like phenotype, which is associated with the suppression of immune responses and facilitation of tumor progression. Interestingly, recent research has highlighted the potential of repolarizing TAMs from an M2 to a pro-inflammatory M1 status-a shift that has shown promise in impeding tumor growth and enhancing immune responsiveness. This concept is particularly intriguing as it offers a new dimension to cancer therapy by targeting the tumor microenvironment, which is a significant departure from traditional approaches that focus solely on tumor cells. However, the clinical application of TAM-modulating agents is often challenged by issues such as insufficient tumor accumulation and off-target effects, limiting their effectiveness and safety. In this regard, nanomaterials have emerged as a novel solution. They serve a dual role: as delivery vehicles that can enhance the accumulation of therapeutic agents in the tumor site and as TAM-modulators. This dual functionality of nanomaterials is a significant advancement as it addresses the key limitations of current TAM-modulating strategies and opens up new avenues for more efficient and targeted therapies. This review provides a comprehensive overview of the latest mechanisms and strategies involving nanomaterials in modulating macrophage polarization within the TME. It delves into the intricate interactions between nanomaterials and macrophages, elucidating how these interactions can be exploited to drive macrophage polarization towards a phenotype that is more conducive to anti-tumor immunity. Additionally, the review explores the burgeoning field of TAM-associated nanomedicines in combination with tumor immunotherapy. This combination approach is particularly promising as it leverages the strengths of both nanomedicine and immunotherapy, potentially leading to synergistic effects in combating cancer.

Use of macrophage as a Trojan horse for cancer nanotheranostics

Role of macrophage in nanomedicine-based disease treatment

Engineering Macrophages <i>via</i> Nanotechnology and Genetic Manipulation for Cancer Therapy

Macrophage‐Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention

Leveraging macrophages for cancer theranostics

Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy.

Macrophage-modulating nanomedicine for cancer immunotherapy

Tumor-associated macrophages in nanomaterial-based anti-tumor therapy: as target spots or delivery platforms

Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy

Nanomedicine engulfed by macrophages for targeted tumor therapy

Engineering Macrophages for Cancer Immunotherapy and Drug Delivery

Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy

Engineering macrophages and their derivatives: A new hope for antitumor therapy

Nanomedicine enables spatiotemporally regulating macrophage-based cancer immunotherapy

Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy

Nanoparticles targeting tumor-associated macrophages: A novel anti-tumor therapy

How to use macrophages to realise the treatment of tumour

Macrophages As an Active Tumour-Targeting Carrier of SN38-nanoparticles for Cancer Therapy

Exploiting Macrophages As Targeted Carrier to Guide Nanoparticles into Glioma

Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy

The promising role of tumor-associated macrophages in the treatment of cancer